• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

Introduction to 2-Bromo-6-chloro-4-methylquinoline (CAS No. 18004-64-3)

2-Bromo-6-chloro-4-methylquinoline, identified by the Chemical Abstracts Service Number (CAS No.) 18004-64-3, is a heterocyclic organic compound belonging to the quinoline family. This compound has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its versatile structural framework and potential biological activities. Quinoline derivatives are well-documented for their pharmacological properties, including antimicrobial, antimalarial, and anticancer effects. The presence of bromine and chlorine substituents, along with a methyl group, enhances the compound's reactivity and functionality, making it a valuable scaffold for drug discovery.

The structural features of 2-Bromo-6-chloro-4-methylquinoline contribute to its unique chemical properties. The bromine atom at the 2-position and the chlorine atom at the 6-position introduce electrophilic centers, which are conducive for further functionalization through nucleophilic substitution reactions. Additionally, the methyl group at the 4-position influences the electronic distribution of the quinoline ring, potentially modulating its interaction with biological targets. These structural attributes make it an attractive candidate for synthesizing novel therapeutic agents.

In recent years, there has been a surge in research focused on quinoline derivatives as potential treatments for various diseases. One of the most compelling areas of investigation is their application in oncology. Studies have demonstrated that certain quinoline-based compounds can inhibit the growth of cancer cells by targeting specific molecular pathways involved in tumor progression. For instance, modifications at the 2-, 6-, and 4-positions of the quinoline core have been shown to enhance binding affinity to enzymes such as topoisomerases and kinases, which are critical for cancer cell proliferation.

Moreover, 2-Bromo-6-chloro-4-methylquinoline has shown promise in combating infectious diseases. Antimalarial drugs like chloroquine and quinine are classic examples of quinoline derivatives that have been instrumental in controlling malaria outbreaks. The introduction of halogen atoms into the quinoline scaffold can improve pharmacokinetic properties, such as solubility and bioavailability, which are essential for effective drug delivery. Current research is exploring how modifications like bromination and chlorination can enhance antimalarial activity while reducing side effects associated with older quinoline drugs.

The synthesis of 2-Bromo-6-chloro-4-methylquinoline typically involves multi-step organic reactions starting from readily available precursors. One common synthetic route begins with the Friedel-Crafts alkylation of a chloroquinoline derivative followed by bromination and chlorination at specific positions using appropriate electrophilic reagents. The choice of reaction conditions, such as temperature, solvent system, and catalysts, plays a crucial role in achieving high yields and purity. Advances in synthetic methodologies have enabled more efficient and scalable production processes, facilitating further exploration of this compound's therapeutic potential.

Recent advancements in computational chemistry have also contributed to the study of 2-Bromo-6-chloro-4-methylquinoline. Molecular modeling techniques allow researchers to predict how this compound interacts with biological targets at the atomic level. By simulating these interactions, scientists can identify key binding sites and optimize the structure for improved efficacy. This approach has been particularly useful in designing derivatives with enhanced selectivity and reduced toxicity.

In conclusion, 2-Bromo-6-chloro-4-methylquinoline (CAS No. 18004-64-3) represents a significant compound in pharmaceutical research due to its structural versatility and potential therapeutic applications. Its unique combination of substituents makes it a valuable scaffold for developing new drugs targeting cancers and infectious diseases. Ongoing studies continue to uncover novel ways to leverage its chemical properties for medical benefit, underscoring its importance in modern drug discovery efforts.

• 302939-86-2(2-Bromo-6-methylquinoline)
• 891842-50-5(2-Bromo-6-chloroquinoline)
• 286949-66-4(1H-Indole,2-bromo-5,6-dichloro-)
• 103858-47-5(2-bromo-4,6-dimethylquinoline)
• 64658-04-4(2-Bromo-4-methylquinoline)
• 1246552-90-8(3-bromo-7-chloroisoquinoline)
• 1276056-79-1(3-bromo-6-chloro-isoquinoline)
• 133131-93-8(2-Bromo-6-methyl-4-phenylquinoline)
• 857206-12-3(QUINOLINE, 2-BROMO-4-PHENYL-)
• 690267-05-1(QUINOLINE, 2-BROMO-6-(4-CHLOROPHENYL)-)